Clinical significance of genetic testing in ulcerative colitis and Crohn's disease

Relevance. Defects of innate and acquired immunity, intestinal microflora disorders, environmental factors against the background of genetic predisposition play a role in the development of ulcerative colitis and Crohn's disease. The question of the influence of genetic factors on the appearance of these diseases remains open. The purpose of the study. To develop approaches to assessing the course of ulcerative colitis and Crohn's disease, taking into account mutations of genes regulating tumor necrosis factor (TNF-a), vascular endothelial growth factor (VEGFA), interleukin-6 (IL-6) and polymorphic variants of the CARD15/NOD2 gene (Gly908Arg, Leu3020insC). Materials and methods. Polymorphic gene variants were studied in 50 patients with ulcerative colitis aged 18 to 79 years, 28 men (56%) and 22 women (44%). Age: under 35 years (38%), from 36 to 50 years (30%), over 51 years (32%). According to the extent of the pathological process, patients with total colitis prevailed (84%). Patients with left-sided colitis (14%) or proctitis (2%) were less common. In 28 patients (56%), chronic continuous course was observed, in 14 (28%) — chronic recurrent, in 8 (16%) — acute course. According to the severity of the attack: moderate (42%), light (28%) and heavy (32%) attacks were observed less frequently. Among the examined patients, surgical intervention was performed in 8 patients (16%), the remaining patients (84%) were treated conservatively. The diagnosis of ulcerative colitis was made on the basis of clinic data, ultrasound, colonoscopy, visual assessment of the pathological process during surgery and histological examination of the surgical material. The frequency of two polymorphic variants of the CARD15/NOD2 gene (Gly908Arg, Leu3020insC) was studied in 40 patients with Crohn's disease. All patients were admitted to the surgical hospital in an emergency. The diagnosis of Crohn's disease was made on the basis of clinic data, ultrasound examination, visual assessment of the pathological process during surgery and histological examination of the surgical material. The studies were conducted within a period of 1 to 10 years from the moment of discharge from the hospital. Results. In ulcerative colitis, mutations of the gene encoding IL-6 for the homozygous variant G174G occurred in 24%, mutations of the gene encoding VEGFA for the homozygous variant C634C occurred with a frequency of 12%. Mutations in the gene encoding tumor necrosis factor (TNF-α) were not detected in the study group. IL-6 gene mutation is almost equally found among groups of patients who underwent surgery and patients after conservative treatment, namely in 25% and 23.8%, respectively. However, mutations of the VEGFA gene were significantly more common (p=0.03) among patients with a history of surgical treatment (37.5%). Genetic testing in patients with ulcerative colitis makes it possible to predict the effectiveness of therapeutic measures, the likelihood of an increased risk of surgical treatment and can act as one of the criteria for the implementation of a personalized approach in this contingent of patients. In patients with Crohn's disease, polymorphisms of the CARD15/NOD2 gene according to the heterozygous variant occurred with a frequency of 35%, polymorphic variant Leu3020insC in 30% of patients, Gly908Arg in 2.5% of cases. Both polymorphic variants were observed in 2.5% of patients. The polymorphic variant Leu3020insC is associated with the localization of a pathological focus and dominates inflammation in the area of the ileocecal angle. Conclusions. In ulcerative colitis, the frequency of IL-6 gene mutations reaches 24%. Mutations of the VEGFA gene were 2 times less common (12%). Mutations in the TNF-α gene were not detected. It was found that mutations in the IL-6 gene are more common among male patients older than 51 years. According to the length of the process, IL-6 gene mutations are associated with left-sided colitis, and EGFR mutations with total intestinal damage. Mutation of the VEGFA gene to a certain extent may indicate the likelihood of an increased risk of surgical treatment. In Crohn's disease, the frequency of gene polymorphism reaches 35%. The polymorphic variant Leu3020insC is associated with the localization of a pathological focus and dominates inflammation in the area of the ileocecal angle. The appearance of a polymorphic variant of Gly908Arg to a certain extent may indicate a possible relapse of the disease.

1. Хохлов А.Л., Рыбачков В.В., Березняк Н.В. Частота полиморфизма гена CARD15/NOD2 при болезни Крона. Вестник Национального медико-хирургического Центра им. Н. И. Пирогова. 2019;1:53-55. [Khokhlov AL, Rybachkov VV, Bereznyak NV. The frequency of CARD15/NOD2 polymorphism in Crohn’s disease. Bulletin of Pirogov Nacional Medical&Sergical center. 2019;1:53-55. (In Russ).] doi: 10.25881/BPNMSC.2019.57.42.011

2. Ивашкин В.Т., Шелыгин Ю.А., Белоусова Е.А., Абдулганиева Д.И., Алексеева О.А., Ачкасов С.И., Валуйских Е.Ю., Варданян А.В., Веселов А.В., Веселов В.В., Головенко О.В., Губонина И.В., Жигалова Т.Н., Кашников В.Н., Князев О.В., Макарчук П.А., Москалев А.И., Нанаева Б.А., Низов А.А., Никитина Н.В., Николаева Н.Н., Павленко В.В., Полуэктова Е.А., Светлова И.О., Тарасова Л.В., Ткачев А.В., Фролов С.А., Хлынова О.В., Чашкова Е.Ю., Шапина М.В., Шептулин А.А., Шифрин О.С., Щукина О.Б. Проект клинических рекомендаций по диагностике и лечению язвенного колита. Колопроктология. 2019;18(4):7-36. https://doi.org/10.33878/2073-7556-2019-18-4-7-36 [Ivashkin V.T., Shelygin Yu.A., Belousova E.A., Abdulganieva D.I., Alekseeva O.A., Achkasov S.I., Valuiskikh E.Yu., Vardanyan A.V., Veselov A.V., Veselov V.V., Golovenko O.V., Gubonina I.V., Zhigalova T.N., Kashnikov V.N., Knyazev O.V., Makarchuk P.A., Moskaliev A.I., Nanaeva B.A., Nizov A.A., Nikitina N.V., Nikolaeva N.N., Pavlenko V.V., Poluektova E.A., Svetlova I.O., Tarasova L.V., Tkachev A.V., Frolov S.A., Khlynova O.V., Chashkova E.Yu., Shapina M.V., Sheptulin A.A., Shifrin O.S., Shchukina O.B. Project: clinical guidelines for the diagnostics and treatment of ulcerative colitis. Koloproktologia. 2019;18(4):7-36.].

3. Satsangi J, Jewell DP, Bell JI. The genetics of inflammatory bowel disease. Gut. 1997 May;40(5):572-4. doi: 10.1136/gut.40.5.572. PMID: 9203931; PMCID: PMC1027155.

4. Kirsner JВ, Spencer JA. Family occurrences of ulcerative colitis, regional enteritis, and ileocolitis. Ann Intern Med. 1963 Aug;59:133-44. doi: 10.7326/0003-4819-59-2-133. PMID: 14049341.

5. Дорофеев А.Э., Звягинцева Т.Д., Харченко Н.В. Заболевания кишечника. - Горловка: ПП «Видавництво Лiхтар», 2010. - 532 с. [Dorofeev AE, Zvyagintseva TD, Kharchenko NV. Intestinal diseases. - Gorlovka: PP "Vydavnitstvo Likhtar", 2010. - 532 p. (In Russ).]

6. Bengtson MB, Solberg IC, Aamodt G, Jahnsen J, Moum B, Vatn MH; IBSEN Study Group. Relationships between inflammatory bowel disease and perinatal factors: both maternal and paternal disease are related to preterm birth of offspring. Inflamm Bowel Dis. 2010 May;16(5):847-55. doi: 10.1002/ibd.21120. PMID: 19795509.

7. McGovern DP, van Heel DA, Ahmad T, Jewell DP. NOD2 (CARD15), the first susceptibility gene for Crohn's disease. Gut. 2001 Dec;49(6):752-4. doi: 10.1136/gut.49.6.752. PMID: 11709505; PMCID: PMC1728539.

8. Peeters M, Vermeire S, Rutgeerts P. Genetics and IBD: What to tell our patients today? Falk Symp. 1998;106:11.

9. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cézard JP, Belaiche J, Almer S, Tysk C, O'Morain CA, Gassull M, Binder V, Finkel Y, Cortot A, Modigliani R, Laurent-Puig P, Gower-Rousseau C, Macry J, Colombel JF, Sahbatou M, Thomas G. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature. 2001 May 31;411(6837):599-603. doi: 10.1038/35079107. PMID: 11385576.

10. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, Britton H, Moran T, Karaliuskas R, Duerr RH, Achkar JP, Brant SR, Bayless TM, Kirschner BS, Hanauer SB, Nuñez G, Cho JH. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature. 2001 May 31;411(6837):603-6. doi: 10.1038/35079114. PMID: 11385577.

11. Ahmad T, Armuzzi A, Bunce M, et al. The molecular classification of the clinical manifestations of Crohn's disease. Gastroenterology. 2002 Apr;122(4):854-866. DOI: 10.1053/gast.2002.32413. PMID: 11910336.

12. Cuthbert AP, Fisher SA, Mirza MM, King K, Hampe J, Croucher PJ, Mascheretti S, Sanderson J, Forbes A, Mansfield J, Schreiber S, Lewis CM, Mathew CG. The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology. 2002 Apr;122(4):867-74. doi: 10.1053/gast.2002.32415. PMID: 11910337.

13. Hampe J, Grebe J, Nikolaus S, Solberg C, Croucher PJ, Mascheretti S, Jahnsen J, Moum B, Klump B, Krawczak M, Mirza MM, Foelsch UR, Vatn M, Schreiber S. Association of NOD2 (CARD 15) genotype with clinical course of Crohn's disease: a cohort study. Lancet. 2002 May 11;359(9318):1661-5. doi: 10.1016/S0140-6736(02)08590-2. PMID: 12020527.

14. Vermeire S, Wild G, Kocher K, et al. CARD15 genetic variation in a Quebec population: prevalence, genotype-phenotype relationship, and haplotype structure. American Journal of Human Genetics. 2002 Jul;71(1):74-83. DOI: 10.1086/341124. PMID: 12019468; PMCID: PMC384994.

15. Sands BE, Siegel CA. Crohn’s disease. In: Feldman M, Friedman LS, Brandt LJ, eds. Sleisenger & Fordtran’s Gastrointestinal and Liver Disease. 9th ed. Philadelphia, Pa: Saunders Elsevier. 2010; chap 111

16. Насыхова Ю.А. и др. Анализ полиморфизма генов NOD2/ CARD15 и TNF-α у пациентов с хроническими воспалительными заболеваниями желудочно-кишечного тракта. Молекулярная медицина. 2010;3:32–37. [Nasykhova YuA et al. Analysis of polymorphism of NOD2/CARD15 and TNFA genes in patients with chronic inflammatory bowel diseases. Molecular Medicine. 2010;3:32-37. (In Russ).]

17. Валуйских Е.Ю. Влияние генетических и средовых факторов на клинические проявления хронических воспалительных заболеваний кишечника (болезнь Крона и неспецифический язвенный колит). Автореф. дис. … канд. мед. наук. Новосибирск.2012;21. [Valujskih EYU. Vliyanie geneticheskih i sredovyh faktorov na klinicheskie proyavleniya hronicheskih vospalitel'nyh zabolevanij kishechnika (bolezn' Krona i nespecificheskij yazvennyj kolit). Avtoref. dis. … kand. med. nauk. Novosibirsk.2012;21. (In Russ).]

18. Макейкина М. А., Ливзан М. А. Генетические прогностические факторы течения неспецифического язвенного колита. Практическая медицина. 2012;9(65):133–136. [Makeikina MA, Livzan MA. Genetic prognostic factors of course of nonspecific ulcerative colitis. Practical medicine. 2012;9(65):133-136. (In Russ).]

19. Шумилов П.В. и др. Полиморфизм генов NOD2/CARD15, OCTN1 и OCTN2 у 5 детей с болезнью Крона и язвенным колитом. Лечение и профилактика. 2011;1:16–21. [Shumilov PV et al. Polymirfizm genov NOD2/CARD15, OCTN1 i OCTN2 u 5 detey s bolezniu Krona i yazvennim kolitom. Lechenie i profilactika. 2011;1: 16-21. (In Russ).]

20. Рыбачков В.В., Хохлов А.Л., Сорогин С.А., Березняк Н.В. Частота мутаций генов TNFα, VEGFА, IL6 при язвенном колите. Вестник НМХЦ им. Н.И. Пирогова. 2022;17(2):49-51. https://doi.org/10.25881/20728255_2022_17_2_49 [Rybachkov VV, Khokhlov AL, Sorogin SA, Bereznyak NV. The frequency of mutations of TNFa, VEGFA, IL-6 genes in ulcerative colitis. Bulletin of Pirogov Nacional Medical&Sergical center. 2022;1:49-51. (In Russ).].

21. Barkhordari E, Rezaei N, Ansaripour B, et al. Proinflammatory cytokine gene polymorphisms in irritable bowel syndrome. Journal of Clinical Immunology. 2010 Jan;30(1):74-79. DOI: 10.1007/s10875-009-9342-4. PMID: 19844779.

22. Stankovic B, Dragasevic S, Popovic D, et al. Variations in inflammatory genes as molecular markers for prediction of inflammatory bowel disease occurrence. Journal of Digestive Diseases. 2015 Dec;16(12):723-733. DOI: 10.1111/1751-2980.12281. PMID: 26316104.

23. Стёпина Е.А., Хлынова О.В., Туев А.В. Диагностическая и прогностическая значимость маркеров эндотелиальной дисфункции у пациентов с язвенным колитом. Казанский медицинский журнал. 2016;97(2):187-191. [Stepina EA, Khlynova OV, Tuev AV. Diagnostic and prognostic value of endothelial dysfunction markers in patients with ulcerative colitis. Kazan med journal. 2016;97(2):187-191. (in Russ).] doi: 10.17750/KMJ2016-187

24. Alkim C, Savas B, Ensari A, Alkim H, Dagli U, Parlak E, Ulker A, Sahin B. Expression of p53, VEGF, microvessel density, and cyclin-D1 in noncancerous tissue of inflammatory bowel disease. Dig Dis Sci. 2009 Sep;54(9):1979-84. doi: 10.1007/s10620-008-0554-x. Epub 2008 Nov 26. PMID: 19034659.

25. Inohara N, Ogura Y, Fontalba A, et al. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. The Journal of Biological Chemistry. 2003 Feb;278(8):5509-5512. DOI: 10.1074/jbc.c200673200. PMID: 12514169